Kickstart Your 2025 ADC Development at the 15th World ADC London
Maximise the Therapeutic Index & Accelerate Your ADC Journey from Concept to Approved Therapy
Antibody-drug conjugates remain front and centre of the biopharma world. Following Enhertu’s historic agnostic approval in HER2-positive solid tumours and TIVDAK winning full approval, the field has seen a surge in multi-billion-dollar acquisitions, commercialisation deals, and licensing agreements. These developments have enabled the ADC community to make strides in bringing these therapies to earlier-line treatments and expand their use to wider patient populations.
Returning for its 15th anniversary year, World ADC London is the leading European conference uniting over 1000 ADC enthusiasts to maximise the therapeutic index of ADCs. Whether you are brand new to the field or have over a decade of experience, work in discovery or manufacturing, hold a strategic position or work day-to-day in the lab, this meeting offers something for you!
Don’t miss this chance to unlock unmissable R&D, focused industry networking opportunities, and emerging trends taking hold of the ADC field with sessions from 120+ world-leading speakers including Daiichi Sankyo, AstraZeneca, Pfizer, AbbVie, Merck, GSK, Johnson & Johnson, ADC Therapeutics and more.
FULL EVENT GUIDE
Scientific Content From Bench To Bedside For All Members Of Your Team
Whether you have just ventured into the ADC space or are an ADC guru, the World ADC London Conference 2024 had you covered.
Your 110+ World Class Speaker Faculty Includes
Alain Beck
Senior Director, Biologics Chemistry, Manufacturing & Controls Developability
Pierre Fabre
Pavan Vajjah
Executive Director, Global Head ADC Clinical Pharmacology & Safety Sciences
AstraZeneca
Hear What Previous Attendees have Said:
"Great experience! I really enjoyed the talks and the panel discussions covering different areas of expertise which matter for ADC development"C development"
Heidelberg Pharma
"World ADC London is the number one ADC meeting in Europe"
Pierre Fabre Group
"This is the greatest ADC conference, we have an excellent update on all aspects of ADCs and innovation across the globe"
Innate Pharma
Proud to Partner With
Lead Partner
Senior Partners
Programme Partners
Exhibition Partners
About World ADC Series
The World ADC team ploughs its collective energy in to sourcing the insights you need. We investigate the most challenging problems facing the industry; source the leading experts who have game-changing solutions; and distil this into accessible formats of information exchange – for you. From globally leading conferences to webinars and industry reports, whatever the information you need, World ADC can offer you the insights you need to accelerate your ADC programs.
The value World ADC provides you is the power of insight and connections. Not artificial, and not short-lived. We nurture the right environments in which people can communicate problems and solutions; share novel data and forge networks across the industry that will make each of your endeavours more informed and more robust.
We share a common belief with the industry – that the potential of antibody drug conjugates is enormous. In the war against cancer, ADCs can be a game-changer and we know that the right insights and connections can sharpen the weapons that are in your arsenal.
Join us at the heart of the ADC community to improve your programmes and be part of the mission to develop better antibody drug conjugate drugs.
